Cervical human papillomavirus infection among young women engaged in sex work in Phnom Penh, Cambodia: prevalence, genotypes, risk factors and association with HIV infection

BMC Infectious Diseases

Volumn 12, Issue , 2012, Pages

  Couture, Marie Claude ^a   Page, Kimberly ^a   Stein, Ellen S ^a   Sansothy, Neth ^b   Sichan, Keo ^c   Kaldor, John ^d   Evans, Jennifer L ^a   Maher, Lisa ^d   Palefsky, Joel ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b AIDS   (Cambodia)

^c Cambodian Women's Development Agency   (Cambodia)

^d UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

WART VIRUS VACCINE;

ADOLESCENT; ADULT; ARTICLE; CAMBODIA; CHEMOLUMINESCENCE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DEMOGRAPHY; DISEASE ASSOCIATION; FEMALE; GENOTYPE; HIGH RISK POPULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; MAJOR CLINICAL STUDY; PAPILLOMAVIRUS INFECTION; POLYMERASE CHAIN REACTION; PREVALENCE; PROSTITUTION; RISK FACTOR; SCREENING; UTERINE CERVIX; VIRUS STRAIN;

ADOLESCENT; ADULT; CAMBODIA; CERVIX UTERI; CROSS-SECTIONAL STUDIES; DNA, VIRAL; FEMALE; GENOTYPE; HIV INFECTIONS; HUMANS; OLIGONUCLEOTIDE PROBES; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; PREVALENCE; RISK FACTORS; SEX WORKERS; YOUNG ADULT;

EID: 84864228726     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-12-166     Document Type: Article

References (60)

1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. GLOBOCAN 2008 v1.2, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10 [Internet] 2010, International Agency for Research on Cancer, Lyon, France.
2. Monchy D, Lieng CR, Kruy LS, Kahler K, Eav S. Diagnosis and treatment of invasive cervical cancer in Cambodia (apropos of 35 cases). Bull Soc Pathol Exot 2005, 98(3):183-186.
3. Bosch FX, Manos MM, Munoz N, Sherman M, Jansen AM, Peto J, Schiffman MH, Moreno V, Kurman R, Shah KV. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group. J Natl Cancer Inst 1995, 87(11):796-802. 10.1093/jnci/87.11.796, 7791229.
4. Franco EL, Rohan TE, Villa LL. Epidemiologic evidence and human papillomavirus infection as a necessary cause of cervical cancer. J Natl Cancer Inst 1999, 91(6):506-511. 10.1093/jnci/91.6.506, 10088620.
5. Castellsague X. Natural history and epidemiology of HPV infection and cervical cancer. Gynecol Oncol 2008, 110(3 Suppl 2):S4-S7.
6. Hernandez BY, Vu Nguyen T. Cervical human papillomavirus infection among female sex workers in southern Vietnam. Infect Agent Cancer 2008, 3:7. 10.1186/1750-9378-3-7, 2405771, 18433504.
7. Domingo EJ, Noviani R, Noor MR, Ngelangel CA, Limpaphayom KK, Thuan TV, Louie KS, Quinn MA. Epidemiology and prevention of cervical cancer in Indonesia, Malaysia, the Philippines, Thailand and Vietnam. Vaccine 2008, 26(Suppl 12):M71-M79.
8. Vet JN, de Boer MA, van den Akker BE, Siregar B, Lisnawati, Budiningsih S, Tyasmorowati D, Moestikaningsih, Cornain S, Peters AA, et al. Prevalence of human papillomavirus in Indonesia: a population-based study in three regions. Br J Cancer 2008, 99(1):214-218. 10.1038/sj.bjc.6604417, 2453028, 18609756.
9. Miyashita M, Agdamag DM, Sasagawa T, Matsushita K, Salud LM, Salud CO, Saikawa K, Leano PS, Pagcaliwagan T, Acuna J, et al. High-risk HPV types in lesions of the uterine cervix of female commercial sex workers in the Philippines. J Med Virol 2009, 81(3):545-551. 10.1002/jmv.21416, 19152419.
10. Chansaenroj J, Lurchachaiwong W, Termrungruanglert W, Tresukosol D, Niruthisard S, Trivijitsilp P, Sampatanukul P, Poovorawan Y. Prevalence and genotypes of human papillomavirus among Thai women. Asian Pac J Cancer Prev 2010, 11(1):117-122.
11. Harper DM, Franco EL, Wheeler CM, Moscicki AB, Romanowski B, Roteli-Martins CM, Jenkins D, Schuind A, Costa Clemens SA, Dubin G. Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial. Lancet 2006, 367(9518):1247-1255. 10.1016/S0140-6736(06)68439-0, 16631880.
12. Joura EA, Leodolter S, Hernandez-Avila M, Wheeler CM, Perez G, Koutsky LA, Garland SM, Harper DM, Tang GW, Ferris DG, et al. Efficacy of a quadrivalent prophylactic human papillomavirus (types 6, 11, 16, and 18) L1 virus-like-particle vaccine against high-grade vulval and vaginal lesions: a combined analysis of three randomised clinical trials. Lancet 2007, 369(9574):1693-1702. 10.1016/S0140-6736(07)60777-6, 17512854.
13. Lu B, Kumar A, Castellsague X, Giuliano AR. Efficacy and safety of prophylactic vaccines against cervical HPV infection and diseases among women: a systematic review & meta-analysis. BMC Infect Dis 2011, 11:13. 10.1186/1471-2334-11-13, 3034689, 21226933.
14. Palefsky JM, Holly EA. Molecular virology and epidemiology of human papillomavirus and cervical cancer. Cancer Epidemiol Biomarkers Prev 1995, 4(4):415-428.
15. Burk RD, Ho GY, Beardsley L, Lempa M, Peters M, Bierman R. Sexual behavior and partner characteristics are the predominant risk factors for genital human papillomavirus infection in young women. J Infect Dis 1996, 174(4):679-689. 10.1093/infdis/174.4.679, 8843203.
16. Sellors JW, Karwalajtys TL, Kaczorowski J, Mahony JB, Lytwyn A, Chong S, Sparrow J, Lorincz A. Incidence, clearance and predictors of human papillomavirus infection in women. Cmaj 2003, 168(4):421-425. 143547, 12591782.
17. Trottier H, Franco EL. The epidemiology of genital human papillomavirus infection. Vaccine 2006, 24(Suppl 1):S1-S15.
18. Hawes SE, Critchlow CW, Faye Niang MA, Diouf MB, Diop A, Toure P, Aziz Kasse A, Dembele B, Salif Sow P, Coll-Seck AM, et al. Increased risk of high-grade cervical squamous intraepithelial lesions and invasive cervical cancer among African women with human immunodeficiency virus type 1 and 2 infections. J Infect Dis 2003, 188(4):555-563. 10.1086/376996, 12898443.
19. Palefsky JM. Cervical human papillomavirus infection and cervical intraepithelial neoplasia in women positive for human immunodeficiency virus in the era of highly active antiretroviral therapy. Curr Opin Oncol 2003, 15(5):382-388. 10.1097/00001622-200309000-00007, 12960521.
20. Adjorlolo-Johnson G, Unger ER, Boni-Ouattara E, Toure-Coulibaly K, Maurice C, Vernon SD, Sissoko M, Greenberg AE, Wiktor SZ, Chorba TL. Assessing the relationship between HIV infection and cervical cancer in Cote d'Ivoire: a case-control study. BMC Infect Dis 2010, 10:242. 10.1186/1471-2334-10-242, 2933704, 20716343.
21. Palefsky JM, Minkoff H, Kalish LA, Levine A, Sacks HS, Garcia P, Young M, Melnick S, Miotti P, Burk R. Cervicovaginal human papillomavirus infection in human immunodeficiency virus-1 (HIV)-positive and high-risk HIV-negative women. J Natl Cancer Inst 1999, 91(3):226-236. 10.1093/jnci/91.3.226, 10037100.
22. Ahdieh L, Klein RS, Burk R, Cu-Uvin S, Schuman P, Duerr A, Safaeian M, Astemborski J, Daniel R, Shah K. Prevalence, incidence, and type-specific persistence of human papillomavirus in human immunodeficiency virus (HIV)-positive and HIV-negative women. J Infect Dis 2001, 184(6):682-690. 10.1086/323081, 11517428.
23. Choi BS, Kim O, Park MS, Kim KS, Jeong JK, Lee JS. Genital human papillomavirus genotyping by HPV oligonucleotide microarray in Korean commercial sex workers. J Med Virol 2003, 71(3):440-445. 10.1002/jmv.10498, 12966552.
24. Mak R, Van Renterghem L, Cuvelier C. Cervical smears and human papillomavirus typing in sex workers. Sex Transm Infect 2004, 80(2):118-120. 10.1136/sti.2002.003749, 1744807, 15054172.
25. Couture MC, Sansothy N, Sapphon V, Phal S, Sichan K, Stein E, Evans J, Maher L, Kaldor J, Vun MC, et al. Young women engaged in sex work in Phnom Penh, Cambodia, have high incidence of HIV and sexually transmitted infections, and amphetamine-type stimulant use: new challenges to HIV prevention and risk. Sex Transm Dis 2010, 38(1):33-39.
26. Strickler HD, Palefsky JM, Shah KV, Anastos K, Klein RS, Minkoff H, Duerr A, Massad LS, Celentano DD, Hall C, et al. Human papillomavirus type 16 and immune status in human immunodeficiency virus-seropositive women. J Natl Cancer Inst 2003, 95(14):1062-1071. 10.1093/jnci/95.14.1062, 12865452.
27. Qu W, Jiang G, Cruz Y, Chang CJ, Ho GY, Klein RS, Burk RD. PCR detection of human papillomavirus: comparison between MY09/MY11 and GP5+/GP6+ primer systems. J Clin Microbiol 1997, 35(6):1304-1310. 229739, 9163434.
28. Munoz N, Bosch FX, de Sanjose S, Herrero R, Castellsague X, Shah KV, Snijders PJ, Meijer CJ. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003, 348(6):518-527. 10.1056/NEJMoa021641, 12571259.
29. Couture MC, Evans JL, Sothy NS, Stein ES, Sichan K, Maher L, Page K. Correlates of amphetamine-type stimulant use and associations with HIV-related risks among young women engaged in sex work in Phnom Penh 2011, Cambodia, Drug Alcohol Depend.
30. Boerma JT, Weir SS. Integrating demographic and epidemiological approaches to research on HIV/AIDS: the proximate-determinants framework. J Infect Dis 2005, 191(Suppl 1):S61-S67.
31. Ishi K, Suzuki F, Saito A, Kubota T. Prevalence of human papillomavirus, Chlamydia trachomatis, and Neisseria gonorrhoeae in commercial sex workers in Japan. Infect Dis Obstet Gynecol 2000, 8(5-6):235-239. 1784698, 11220484.
32. De Marco F, Houissa-Kchouk F, Khelifa R, Marcante ML. High-risk HPV types in Tunisia. A pilot study reveals an unexpectedly high prevalence of types 58 and 82 and lack of HPV 18 among female prostitutes. J Med Virol 2006, 78(7):950-953. 10.1002/jmv.20646, 16721861.
33. Langley CL, Benga-De E, Critchlow CW, Ndoye I, Mbengue-Ly MD, Kuypers J, Woto-Gaye G, Mboup S, Bergeron C, Holmes KK, et al. HIV-1, HIV-2, human papillomavirus infection and cervical neoplasia in high-risk African women. AIDS 1996, 10(4):413-417. 10.1097/00002030-199604000-00010, 8728046.
34. Shikova E, Todorova I, Ganchev G, Kouseva-Dragneva V, Kalascheva-Zaimova P. Prevalence of human papillomavirus infection among female sex workers in Bulgaria. Int J STD AIDS 2011, 22(5):278-280. 10.1258/ijsa.2009.009362, 21571976.
35. Luchters SM, Vanden Broeck D, Chersich MF, Nel A, Delva W, Mandaliya K, Depuydt CE, Claeys P, Bogers JP, Temmerman M. Association of HIV infection with distribution and viral load of HPV types in Kenya: a survey with 820 female sex workers. BMC Infect Dis 2010, 10:18. 10.1186/1471-2334-10-18, 2845133, 20102630.
36. Brown VL, Jane White KA. The role of optimal control in assessing the most cost-effective implementation of a vaccination programme: HPV as a case study. Math Biosci 2011, 231(2):126-134. 10.1016/j.mbs.2011.02.009, 21377481.
37. de Boer MA, Vet JN, Aziz MF, Cornain S, Purwoto G, van den Akker BE, Dijkman A, Peters AA, Fleuren GJ. Human papillomavirus type 18 and other risk factors for cervical cancer in Jakarta, Indonesia. Int J Gynecol Cancer 2006, 16(5):1809-1814. 10.1111/j.1525-1438.2006.00701.x, 17009976.
38. Paavonen J, Naud P, Salmeron J, Wheeler CM, Chow SN, Apter D, Kitchener H, Castellsague X, Teixeira JC, Skinner SR, et al. Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women. Lancet 2009, 374(9686):301-314. 10.1016/S0140-6736(09)61248-4, 19586656.
39. Wheeler CM, Castellsague X, Garland SM, Szarewski A, Paavonen J, Naud P, Salmeron J, Chow SN, Apter D, Kitchener H, et al. Cross-protective efficacy of HPV-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by non-vaccine oncogenic HPV types: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial. Lancet Oncol 2012, 13(1):100-110. 10.1016/S1470-2045(11)70287-X, 22075170.
40. Clifford GM, Goncalves MA, Franceschi S. Human papillomavirus types among women infected with HIV: a meta-analysis. AIDS 2006, 20(18):2337-2344. 10.1097/01.aids.0000253361.63578.14, 17117020.
41. Chin-Hong PV, Husnik M, Cranston RD, Colfax G, Buchbinder S, Da Costa M, Darragh T, Jones D, Judson F, Koblin B, et al. Anal human papillomavirus infection is associated with HIV acquisition in men who have sex with men. AIDS 2009, 23(9):1135-1142. 10.1097/QAD.0b013e32832b4449, 19390418.
42. Auvert B, Lissouba P, Cutler E, Zarca K, Puren A, Taljaard D. Association of oncogenic and nononcogenic human papillomavirus with HIV incidence. J Acquir Immune Defic Syndr 2010, 53(1):111-116. 10.1097/QAI.0b013e3181b327e7, 3203884, 19779357.
43. Veldhuijzen NJ, Vyankandondera J, van de Wijgert JH. HIV acquisition is associated with prior high-risk human papillomavirus infection among high-risk women in Rwanda. AIDS 2010, 24(14):2289-2292. 10.1097/QAD.0b013e32833cbb71, 20613457.
44. Smith-McCune KK, Shiboski S, Chirenje MZ, Magure T, Tuveson J, Ma Y, Da Costa M, Moscicki AB, Palefsky JM, Makunike-Mutasa R, et al. Type-specific cervico-vaginal human papillomavirus infection increases risk of HIV acquisition independent of other sexually transmitted infections. PLoS One 2010, 5(4):e10094. 10.1371/journal.pone.0010094, 2851652, 20386706.
45. Wilkin T, Lee JY, Lensing SY, Stier EA, Goldstone SE, Berry JM, Jay N, Aboulafia D, Cohn DL, Einstein MH, et al. Safety and immunogenicity of the quadrivalent human papillomavirus vaccine in HIV-1-infected men. J Infect Dis 2010, 202(8):1246-1253. 10.1086/656320, 3118428, 20812850.
46. Levin MJ, Moscicki AB, Song LY, Fenton T, Meyer WA, Read JS, Handelsman EL, Nowak B, Sattler CA, Saah A, et al. Safety and immunogenicity of a quadrivalent human papillomavirus (types 6, 11, 16, and 18) vaccine in HIV-infected children 7 to 12 years old. J Acquir Immune Defic Syndr 2010, 55(2):197-204. 10.1097/QAI.0b013e3181de8d26, 3033215, 20574412.
47. Maher L, Phlong P, Mooney-Somers J, Keo S, Stein E, Couture MC, Page K. Amphetamine-type stimulant use and HIV/STI risk behaviour among young female sex workers in Phnom Penh 2011, Cambodia, The International journal on drug policy.
48. Molitor F, Truax SR, Ruiz JD, Sun RK. Association of methamphetamine use during sex with risky sexual behaviors and HIV infection among non-injection drug users. West J Med 1998, 168(2):93-97. 1304836, 9499742.
49. Buchacz K, McFarland W, Kellogg TA, Loeb L, Holmberg SD, Dilley J, Klausner JD. Amphetamine use is associated with increased HIV incidence among men who have sex with men in San Francisco. AIDS 2005, 19(13):1423-1424. 10.1097/01.aids.0000180794.27896.fb, 16103774.
50. Patterson TL, Semple SJ, Staines H, Lozada R, Orozovich P, Bucardo J, Philbin MM, Pu M, Fraga M, Amaro H, et al. Prevalence and correlates of HIV infection among female sex workers in 2 Mexico-US border cities. J Infect Dis 2008, 197(5):728-732. 10.1086/527379, 2872174, 18260766.
51. Liao M, Jiang Z, Zhang X, Kang D, Bi Z, Liu X, Fu J, Zhang N, Mao W, Jiang B, et al. Syphilis and methamphetamine use among female sex workers in Shandong Province, China. Sex Transm Dis 2010, 38(1):57-62.
52. Minkoff HL, McCalla S, Delke I, Stevens R, Salwen M, Feldman J. The relationship of cocaine use to syphilis and human immunodeficiency virus infections among inner city parturient women. Am J Obstet Gynecol 1990, 163(2):521-526.
53. Baldwin GC, Roth MD, Tashkin DP. Acute and chronic effects of cocaine on the immune system and the possible link to AIDS. J Neuroimmunol 1998, 83(1-2):133-138.
54. Liang H, Wang X, Chen H, Song L, Ye L, Wang SH, Wang YJ, Zhou L, Ho WZ. Methamphetamine enhances HIV infection of macrophages. Am J Pathol 2008, 172(6):1617-1624. 10.2353/ajpath.2008.070971, 2408421,2408421, 18458095.
55. Nair MP, Saiyed ZM, Nair N, Gandhi NH, Rodriguez JW, Boukli N, Provencio-Vasquez E, Malow RM, Miguez-Burbano MJ. Methamphetamine enhances HIV-1 infectivity in monocyte derived dendritic cells. J Neuroimmune Pharmacol 2009, 4(1):129-139. 10.1007/s11481-008-9128-0, 18958626.
56. Talloczy Z, Martinez J, Joset D, Ray Y, Gacser A, Toussi S, Mizushima N, Nosanchuk JD, Goldstein H, Loike J, et al. Methamphetamine inhibits antigen processing, presentation, and phagocytosis. PLoS Pathog 2008, 4(2):e28. 10.1371/journal.ppat.0040028, 2242831, 18282092.
57. Minkoff H, Zhong Y, Strickler HD, Watts DH, Palefsky JM, Levine AM, D'Souza G, Howard AA, Plankey M, Massad LS, et al. The relationship between cocaine use and human papillomavirus infections in HIV-seropositive and HIV-seronegative women. Infect Dis Obstet Gynecol 2008, 2008:587082. 2324195, 18437233.
58. Minh TT, Nhan DT, West GR, Durant TM, Jenkins RA, Huong PT, Valdiserri RO. Sex workers in Vietnam: how many, how risky?. AIDS Education and prevention : official publication of the International Society for AIDS Education 2004, 16(5):389-404.
59. Choi SY, Holroyd E. The influence of power, poverty and agency in the negotiation of condom use for female sex workers in mainland China. Cult Health Sex 2007, 9(5):489-503. 10.1080/13691050701220446, 17687674.
60. Ministry of Health National Center for HIV, AIDS, Dermatology and STDs. Annual Report 2006. In., vol. 2006 2006, National Center for HIV, AIDS, Dermatology and STD, Phnom Penh, Cambodia, http://www.nchads.org/report.php; Accessed December 18, 2008.